Healthcare & Medical Devices Global On demand · 24-48h

Global Prostate Biopsy Needle Market Strategic Research Report

Global Prostate Biopsy Needle Market Strategic Research Repo…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Prostate Biopsy Needle Market
$7252025
6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Reusable Devices, Disposable Devices

By Application: Hospitals, Ambulatory Surgical Center(ASCs), Diagnostic Centers

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Smiths Detection, Rapiscan Systems, Nuctech Company, Leidos Security Detection, Astrophysics Inc., Varex Imaging, Analogic Corporation, Adani Systems, Autoclear, OSI Systems, CGN Begood, Beijing Vacuum Electronic Technology, Eastimage

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 106 pages
Market size 2025
$725
Million USD
Forecast CAGR
6%
2025-2032
Forecast 2032
$1090.1
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Prostate Biopsy Needle market size is predicted to grow from US$ 725 million in 2025 to US$ 1,084 million in 2032; it is expected to grow at a CAGR of 6.0% from 2026 to 2032.

A prostate biopsy needle is a medical device designed to obtain tissue samples from the prostate gland for pathological examination, primarily used to diagnose prostate cancer and other prostate abnormalities. These needles are typically used in conjunction with ultrasound-guided biopsy systems and spring-loaded biopsy guns to accurately collect core tissue samples with minimal invasiveness. Compared with traditional surgical diagnostic procedures, prostate biopsy needles enable faster diagnosis, reduced patient trauma, and improved outpatient workflow efficiency. From a value chain perspective, upstream includes medical-grade stainless steel, polymer components, precision grinding materials, and sterile packaging supplies; midstream focuses on needle fabrication, sharpening, assembly, sterilization, and quality control; downstream demand comes from hospitals, urology clinics, cancer diagnostic centers, and outpatient surgical facilities. In 2025, the average selling price of prostate biopsy needles is approximately US$38.00 per unit, with global sales volume reaching around 19.5 million units. The industry maintains a gross margin of 45%–65%, supported by rising cancer screening programs and recurring procedural usage.

Increasing awareness of prostate cancer screening and improved diagnostic imaging technologies are driving the use of targeted biopsy procedures. MRI–ultrasound fusion biopsy techniques are becoming more widely adopted, increasing demand for high-precision biopsy needles. Manufacturers are focusing on improving needle sharpness, sampling efficiency, and patient comfort while reducing procedure-related complications.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Prostate Biopsy Needle market?

What factors are driving Prostate Biopsy Needle market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Prostate Biopsy Needle market opportunities vary by end market size?

How does Prostate Biopsy Needle break out by Type, by Application?

This report presents a comprehensive overview of the global Prostate Biopsy Needle market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Reusable Devices
  • Disposable Devices

Segment by Needle Type

  • Core Biopsy Needle
  • Fine Needle

Segment by Gauge Size

  • 16G
  • 18G
  • 20G

Segment by Application

  • Hospitals
  • Ambulatory Surgical Center(ASCs)
  • Diagnostic Centers

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Prostate Biopsy Needle market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospitals, Ambulatory Surgical Center(ASCs), Diagnostic Centers evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Prostate Biopsy Needle Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$725
2025
Forecast
$1090.1
2032
CAGR
6%
2025–2032
Régions
5
global
Key companies
Smiths DetectionRapiscan SystemsNuctech CompanyLeidos Security DetectionAstrophysics Inc.Varex ImagingAnalogic CorporationAdani Systems
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Reusable DevicesDisposable Devices
By Application
HospitalsAmbulatory Surgical Center(ASCs)Diagnostic Centers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Reusable Devices
  • 3.1.3 Disposable Devices
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospitals
  • 4.1.3 Ambulatory Surgical Center(ASCs)
  • 4.1.4 Diagnostic Centers
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Smiths Detection
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Rapiscan Systems
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Nuctech Company
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Leidos Security Detection
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Astrophysics Inc.
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Varex Imaging
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Analogic Corporation
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Adani Systems
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Autoclear
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 OSI Systems
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 CGN Begood
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Beijing Vacuum Electronic Technology
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Eastimage
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Prostate Biopsy Needle market size?
The global Prostate Biopsy Needle market is estimated at US$ 725 million in 2025 (base year) and is projected to reach US$ 1.08 billion by 2032.
What growth rate is expected for the Prostate Biopsy Needle market through 2032?
The market is expected to grow at a CAGR of 6.0% from 2026 to 2032, expanding from US$ 725 million in 2025 to US$ 1.08 billion in 2032, roughly 1.5 times its base-year value.
How is Prostate Biopsy Needle defined?
A prostate biopsy needle is a medical device designed to obtain tissue samples from the prostate gland for pathological examination, primarily used to diagnose prostate cancer and other prostate abnormalities. These needles are typically used in conjunction with ultrasound-guided biopsy systems and spring-loaded biopsy guns to accurately collect core tissue samples with minimal invasiveness.
What are the main segments of the Prostate Biopsy Needle market by type?
By type, the market is segmented into Reusable Devices and Disposable Devices.
Which applications drive demand in the Prostate Biopsy Needle market?
Key applications covered include Hospitals, Ambulatory Surgical Center(ASCs) and Diagnostic Centers.
Who are the key players in the Prostate Biopsy Needle market?
Key players profiled include Smiths Detection, Rapiscan Systems, Nuctech Company, Leidos Security Detection, Astrophysics Inc., Varex Imaging, Analogic Corporation and Adani Systems, among 13 companies covered in total.
Which regions and countries are covered for Prostate Biopsy Needle?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Prostate Biopsy Needle market?
Increasing awareness of prostate cancer screening and improved diagnostic imaging technologies are driving the use of targeted biopsy procedures.
Who should buy the Prostate Biopsy Needle market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospitals, Ambulatory Surgical Center(ASCs) and Diagnostic Centers, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Prostate Biopsy Needle market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.